15 March 2021 - Deborah Wilkes
Premium
Hikma Pharmaceuticals and GlaxoSmithKline (GSK) have ended their discussions about a transaction in Egypt and Tunisia.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.